M.D., Ph.D.
Hematologist-Oncologist
M.D., Ph.D.
Alexey Danilov, M.D., Ph.D., is an accomplished researcher and globally recognized expert in chronic lymphocytic leukemia, mantle cell lymphoma and non-Hodgkin lymphoma. At City of Hope® Cancer Center Duarte, he is a professor of hematology and hematopoietic stem cell transplantation and serves in a variety of leadership roles in both the Toni Stephenson Lymphoma Center and City of Hope’s early clinical therapeutics program.
Dr. Danilov—who is both a Leukemia & Lymphoma Society Scholar and the principal investigator on numerous research projects with funding from organizations such as the National Cancer Institute (NCI), the American Society of Hematology, the Lymphoma Research Foundation and the Leukemia & Lymphoma Society—has developed and led dozens of clinical trials exploring innovative targeted therapies and immunotherapies for blood cancers. Through collaborations with the NCI, pharmaceutical companies and the Southwest Oncology Group’s Lymphoma Committee, Dr. Danilov has played an influential role in advancing global drug development efforts for hematologic malignancies.
At City of Hope, Dr. Danilov oversees early-phase clinical research initiatives as part of the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network. In his role with the Toni Stephenson Lymphoma Center, he steers both clinical and translational research focused on leukemia and lymphoma. A strong advocate of translational medicine, Dr. Danilov’s laboratory is dedicated to bridging scientific discoveries with patient care—bringing innovations from the bench to the bedside to benefit patients at Citi of Hope and beyond.